Cargando…
MTBVAC: Attenuating the Human Pathogen of Tuberculosis (TB) Toward a Promising Vaccine against the TB Epidemic
Bacille Calmette-Guérin (BCG) is a live-attenuated strain of Mycobacterium bovis developed a century ago by repeated subculture. It remains the only vaccine against tuberculosis (TB) in use today, and it offers variable protection against the respiratory forms of TB responsible for transmission. The...
Autores principales: | Gonzalo-Asensio, Jesus, Marinova, Dessislava, Martin, Carlos, Aguilo, Nacho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5736532/ https://www.ncbi.nlm.nih.gov/pubmed/29326700 http://dx.doi.org/10.3389/fimmu.2017.01803 |
Ejemplares similares
-
MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against Mycobacterium tuberculosis in Mice
por: Broset, Esther, et al.
Publicado: (2019) -
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice
por: Aguilo, Nacho, et al.
Publicado: (2016) -
Pulmonary MTBVAC vaccination induces immune signatures previously correlated with prevention of tuberculosis infection
por: Dijkman, Karin, et al.
Publicado: (2021) -
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia
por: Tarancón, Raquel, et al.
Publicado: (2020) -
Live attenuated TB vaccines representing the three modern Mycobacterium tuberculosis lineages reveal that the Euro–American genetic background confers optimal vaccine potential
por: Pérez, Irene, et al.
Publicado: (2020)